DDX41 and myelodysplastic syndrome: Previous reports showed that the myeloid neoplasm with the germline DDX41 mutation was slowly progressive and the rate of remission after induction therapy for high-risk MDS/AML with germline DDX41 mutation was high, with a good prognosis.